Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacokinetics
100%
Cytochrome P450 1A2 (CYP1A2)
100%
Pharmacodynamics
100%
Null Mice
100%
Clozapine
100%
Wild Mice
45%
Area under the Curve
27%
Clozapine-N-oxide
18%
Myoclonus
18%
Adverse Effects
9%
Seizure
9%
Blood Samples
9%
Intraperitoneal Injection
9%
Motor Impairment
9%
One Percent
9%
Behavioral Parameters
9%
Poor Metabolizer
9%
Demethylation
9%
Sedation
9%
Extensive Metabolizer
9%
Major Determinants
9%
N-oxidation
9%
HPLC with UV Detection
9%
Pharmacology, Toxicology and Pharmaceutical Science
Knockout Mouse
100%
CYP1A2
100%
Pharmacodynamics
100%
Clozapine
100%
Pharmacokinetics
100%
Wild Type Mouse
45%
Desmethylclozapine
18%
Clozapine N Oxide
18%
Myoclonus
18%
Adverse Event
9%
High Performance Liquid Chromatography
9%
Motor Dysfunction
9%
Intraperitoneal Injection
9%